Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Farminveste SGPSXLIS:MLFMV 65 EBITDA Margin % is 5.24% as of Dec. 2025, which is 2% below its 10-year median of 5.33. GuruFocus rates XLIS:MLFMV with a GF Score™ of 65/100 and a GF Value™ of €1.64 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 117 Medical Distribution companies, Farminveste SGPS ranks better than 60.68% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Farminveste SGPS's EBITDA for the
six
months ended in Dec. 2025 was €24.1 Mil. Farminveste SGPS's Revenue for the
six
months ended in Dec. 2025 was €461.0 Mil. Therefore, Farminveste SGPS's EBITDA margin for the quarter that ended in Dec. 2025 was 5.24%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Farminveste SGPS EBITDA Margin % Related Terms
Farminveste SGPS EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Farminveste SGPS's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XLIS:MLFMV vs MCK, CAH, COR: EBITDA Margin % Comparison
For the Medical Distribution subindustry, Farminveste SGPS's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Farminveste SGPS EBITDA Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Farminveste SGPS's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Farminveste SGPS's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Farminveste SGPS (XLIS:MLFMV) has a EBITDA Margin % of 5.24% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Farminveste SGPS and its competitors. This is near median its historical median of 5.33. Over the past decade, Farminveste SGPS's EBITDA Margin % has ranged from 1.83 to 6.28. According to the industry distribution chart, Farminveste SGPS ranks #46 out of 117 companies in the Medical Distribution industry, placing it in the top 39.3%.
Is Farminveste SGPS's EBITDA Margin % too high?
Farminveste SGPS's current EBITDA Margin % of 5.24% is near median its 10-year median of 5.33. Over the past 10 years, this metric has ranged from a low of 1.83 to a high of 6.28. The Medical Distribution industry median EBITDA Margin % is 4.20. Farminveste SGPS's value of 5.24% is 24.8% above this industry median. Based on the distribution chart, Farminveste SGPS ranks #46 out of 117 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Farminveste SGPS has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Farminveste SGPS's EBITDA Margin % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Farminveste SGPS ranks #46 out of 117 companies for EBITDA Margin %. This puts Farminveste SGPS in the upper half of its industry. The industry median EBITDA Margin % is 4.20. Farminveste SGPS's value of 5.24% is 24.8% above this benchmark. Historically, Farminveste SGPS's own EBITDA Margin % has ranged from 1.83 to 6.28 over the past decade. While the company's 10-year median is 5.33 vs. the industry median of 4.20, Farminveste SGPS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Distribution company?
The median EBITDA Margin % among Medical Distribution companies is 4.20, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Farminveste SGPS's current EBITDA Margin % of 5.24% is 24.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Farminveste SGPS and its competitors. For the Medical Distribution industry, the median EBITDA Margin % is 4.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Farminveste SGPS's current EBITDA Margin % is 5.24%, which is near median its own 10-year median of 5.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farminveste SGPS stock overvalued right now?
Based on GuruFocus' analysis, Farminveste SGPS (XLIS:MLFMV) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.64, compared to a current price of €5.00 — trading 204.9% above its estimated fair value. The current EBITDA Margin % is 5.24%, which is near median its 10-year median of 5.33 and 24.8% above the Medical Distribution industry median of 4.20. Farminveste SGPS's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Farminveste SGPS (XLIS:MLFMV), the current EBITDA Margin % is 5.24% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Farminveste SGPS (XLIS:MLFMV) Overvalued in 2026?
Based on GuruFocus' analysis, Farminveste SGPS stock appears to be overvalued.
The current stock price of €5.00 is trading 204.9% above its estimated GF Value™ of €1.64.
GuruFocus considers Farminveste SGPS to be Significantly Overvalued.
Key valuation signals for XLIS:MLFMV:
EBITDA Margin %: 5.24% (near median its 10-year median of 5.33)
GF Value™: €1.64 vs. price of €5.00 (204.9% above fair value)
Industry Position: 24.8% above the Medical Distribution median (#46 of 117)
No single metric tells the full story. See the XLIS:MLFMV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Farminveste SGPS SA is a holding company and its subsidiaries are active in the business of pharmacies, pharmaceutical distribution, information systems, health care, real estate, market intelligence and other services.
65GF Score
Get the complete analysis for XLIS:MLFMV
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XLIS:MLFMV has been successfully added to your 
